Systematic review: hepatosplenic T-cell lymphoma on biologic therapy for inflammatory bowel disease, including data from the Food and Drug Administration Adverse Event Reporting System. [electronic resource]
Producer: 20200828Description: 527-533 p. digitalISSN:- 1365-2036
- Adolescent
- Adult
- Adverse Drug Reaction Reporting Systems -- statistics & numerical data
- Aged
- Aged, 80 and over
- Biological Products -- therapeutic use
- Child
- Drug-Related Side Effects and Adverse Reactions -- epidemiology
- Female
- Humans
- Inflammatory Bowel Diseases -- drug therapy
- Liver Neoplasms -- chemically induced
- Lymphoma, T-Cell -- chemically induced
- Male
- Middle Aged
- Splenic Neoplasms -- chemically induced
- United States -- epidemiology
- United States Food and Drug Administration
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.